JAK Inhibitor Treatment to Become Available for Ankylosing Spondylitis
First oral JAK Inhibitors option for ankylosing spondylitis.
What does sex have to do with Ankylosing Spondylitis
Who would have thought that sex had anything to do with Ankylosing Spondylitis (AS)
Diagnosing Ankylosing Spondylitis and the Role of HLA B-27 Testing
Frequently asked questions and answers about the Human Leukocyye Antigen B-27 blood test.
The Role & Importance of Nutrition In SLE, RA, AS, PsA and Chronic Inflammation
Nutrition recommendations for managing chronic inflammatory conditions. Answers to FAQ's from Dr Manno of Johns Hopkins.
The Social-Economic Impact of Ankylosing Spondylitis in Women is Significant
Research suggests AS occurs equally in men and women-women are treated differently and experience more negative outcomes
Women With Ankylosing Spondylitis As Likely to Have Normal Pregnancy as Others
Study evaluates risk of pregnancy in women with ankylosing spondylitis.
Update To Treat To Target Recommendations for Ankylosing Spondylitis
Experts update treatment recommendations for ankylosing spondylitis.
More than A Bit of Back Pain: Women and Ankylosing Spondylitis
Research continues to reveal that individuals suffer with back pain for years with undiagnosed AS - There is treatment.
Obesity- More Than a Weight Problem for Arthritis and Spondylitis
Obesity- More Than a Weight Problem for Ankylosing Spondylitis (AS) and Other Rheumatic Conditions
Is Premature Atherosclerosis Associated with Ankylosing Spondylitis (AS)?
Atherosclerosis (ASCVD) or hardening of the arteries is associated with angina, heart attacks and strokes...
Biologic Therapy Can Prevent Radiographic Progression in Axial Spondyloarthritis
Long term anti-TNF therapy with Biologic medications delays progression of spondylitis.
Cosentyx® - Frequently Asked Questions About Cosentyx® (secukinumab)
Understand the administration, side effects and answers to frequently asked questions about Cosentyx® (secukinumab)
Strong Association Between Uveitis and Ankylosing Spondylitis
Dr. Borenstein discusses relationship between back pain and eye symptoms in ankylosing spondylitis.
Frequently Asked Questions About Remicade® (Infliximab)
Understand the administration, side effects and answers to frequently asked questions about Remicade.
Update of Treat to Target Recommendations for Axial Spondylitis
Dr. David Borenstein M.D. reviews recent task force recomendations for management of axial spondylitis
Cosentyx is Effective Therapy for Active Ankylsoing Spondylitis
MEASURE 3 study reports Cosentyx very effective treatment for Ankylosing Sondylitis
Long-term Benefit of Cosentyx in Ankylosing Spondylitis
Spine Community News:
EULAR Update on AS Pregnancy Complications & Extra-Spinal Involvement
Ankylosing Spondylitis has higher risk of pre-term births and extra spinal manifestations than previously thought.
Secukinamab: A New Class of Therapy for Ankylosing Spondylitis Patients
Interleukin-17 (IL-17) is a protein produced by immune cells that you may not think of at any time during your busy day
Frequently Asked Questions About Humira® (Adalimumab)
Understand the administration, side effects and answers to frequently asked questions about Humira.
Rheumatic Disease Therapy and COVID-19 Vaccination - What You Need to Know
The Potential Effect of Rheumatic Disease Therapy and the Efficacy of COVID-19 Vaccinations-ACR Guidelines released.
Managing & Understanding The Pain From Chronic Inflammation
Understand and learn how to cope and manage pain from AS, SLE, RA, PsA and Chronic Inflammation.
Inflammatory Bowel Disease and Ankylosing Spondylitis
Individuals with Crohn's or Ulcerative Colitis and back pain have increased risk of Ankylosing Spondylitis
Cosentyx Approved for Treatment of Non-Radiographic Spondyloarthritis (NR-SPA)
Ankylosing spondylitis (AS) is an inflammatory spinal disease which is associated with...
Taltz receives the indication for treatment of Non-radiographic NR-SPA
Ankylosing spondylitis (AS) is an inflammatory spinal disease which is associated with damage....
Non-radiographic Ankylosing Spondylitis Symptoms Improved with Biologic Therapy
The IL-17A inhibitors Taltz and Cosentyx improve symptoms in non-radiographic Ankylosing Spondylitis
Support and Financial Resource Organizations for Ankylosing Spondylitis
As you learn to navigate life with AS you’ll need two critical things: information and support.
Recommendations for Exercise in Ankylosing Spondylitis
Current expert recommendations for exercise and ankylosing spondylitis.
FDA Authorizes Rapid, Affordable at-Home Testing for COVID-19
Affordable, rapid, home testing options become available for COVID-19 testing.
Certolizumab pegol Effectiveness and Safety in a Real World 12 Month Study
Certolizumab pegol is an anti-Tumor Necrosis Factor antibody that decreases the increased levels of this inflammatory...
Cosentyx® Treatment Benefits Ankylosing Spondylitis Patients Up to 5 years
Research suggests that Cosentyx offers sustained improvement of ankylosing spondylitis symptoms.
Taltz: A New Biologic Therapy for Ankylosing Spondylitis
Lancet study demonstrates Taltz is effective treatment for ankylosing spondylitis - leads to FDA approval.
Cimzia Approved for the Treatment of Non-Radiographic Axial Spondyloarthritis
Cimzia - First Drug Approved by the FDA for the Treatment of "AS Precurser" Non-Radiographic Axial Spondyloarthritis
Dose of TNF Therapy Can Be Lowered in Some Patients with Spondyloarthritis
Study suggests dose of TNF medications may be halved in individuals with low disease activity ankylosing spondylitis
Do Relatives of AS Patients Experience Different Back Pain?
Earlier age of back pain onset and eye symptoms are more common in first degree relatives of AS patients.
Could Single Nucleotide Polymorhphisms Diagnose Ankylosing Spondylitis Earlier?
A new genetic test may become available to help diagnose Ankylosing Spondylitis.
Complete American College of Rheumatology Meeting Coverage from theRAConnection
Learn the key developments presented at ACR for RA, AS, PsA, SLE, and other inflammatory and bone and joint conditions
Understanding Biosimilar Drugs; Are They as Good as They Say?
A new class of medication is available to some patients with chronic inflammatory conditions